|
SUV420H1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15699999972507E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.72889999275839E-09 |
| Normal-vs-Stage2 |
4.160300E-04 |
| Normal-vs-Stage3 |
1.791460E-04 |
| Normal-vs-Stage4 |
2.16829999954982E-07 |
| Stage1-vs-Stage2 |
9.460800E-01 |
| Stage1-vs-Stage3 |
6.776400E-01 |
| Stage1-vs-Stage4 |
1.173990E-01 |
| Stage2-vs-Stage3 |
7.007600E-01 |
| Stage2-vs-Stage4 |
2.317800E-01 |
| Stage3-vs-Stage4 |
3.853600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.00280003482112E-09 |
| Normal-vs-AfricanAmerican |
1.52442999999947E-05 |
| Normal-vs-Asian |
2.150400E-04 |
| Caucasian-vs-AfricanAmerican |
7.532000E-01 |
| Caucasian-vs-Asian |
6.742800E-01 |
| AfricanAmerican-vs-Asian |
5.476400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.6511018914639E-11 |
| Normal-vs-Female |
4.829200E-01 |
| Male-vs-Female |
2.337800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.47459999999089E-05 |
| Normal-vs-Extreme_Weight |
2.4777000451337E-09 |
| Normal-vs-Obese |
1.799590E-04 |
| Normal-vs-Extreme_Obese |
1.43850000000612E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.612200E-01 |
| Normal_Weight-vs-Obese |
3.782400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.261200E-01 |
| Extreme_Weight-vs-Obese |
6.779800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.757600E-01 |
| Obese-vs-Extreme_Obese |
1.282020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.569400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.73878999999433E-05 |
| Normal-vs-Age(61-80Yrs) |
1.75960024328958E-10 |
| Normal-vs-Age(81-100Yrs) |
6.793700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.445000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.879500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.062390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.046200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.454430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.471400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.32330000185621E-08 |
| Normal-VS-Type2 PRCC |
2.43904896279901E-12 |
| Normal-VS-KIRP CIMP |
9.829000E-01 |
| Normal-VS-Unclassified PRCC |
1.415870E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.435920E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.562600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.183000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.668400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.848000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.120600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.11459755156329E-11 |
| Normal-vs-N1 |
1.106760E-01 |
| Normal-vs-N2 |
1.86800000001597E-06 |
| N0-vs-N1 |
2.019900E-02 |
| N0-vs-N2 |
3.206200E-01 |
| N1-vs-N2 |
9.558400E-02 |
|
|
